10 likes | 20 Views
Eosinophilic Esophagitis (EoE) is a chronic, immune-mediated disorder that affects the esophagus. EoE is characterized by the accumulation of eosinophils, a type of white blood cell, in the esophagus. This can cause inflammation and damage to the esophagus, leading to difficulty swallowing, chest pain, and other symptoms. Until recently, treatment options for Eosinophilic Esophagitis were limited. However, the emergence of biologic therapies has opened up new possibilities for Eosinophilic Esophagitis treatment. In this blog, we will explore the growing prevalence of Eosinophilic Esophagitis,
E N D
Is it the Dawn of Biologics in the Eosinophilic Esophagitis Treatment Landscape? Eosinophilic Esophagitis (EoE) is a chronic, immune-mediated disorder that affects the esophagus. EoE is characterized by the accumulation of eosinophils, a type of white blood cell, in the esophagus. This can cause inflammation and damage to the esophagus, leading to difficulty swallowing, chest pain, and other symptoms. Until recently, treatment options for Eosinophilic Esophagitis were limited. However, the emergence of biologic therapies has opened up new possibilities for Eosinophilic Esophagitis treatment. In this blog, we will explore the growing prevalence of Eosinophilic Esophagitis, the promising Eosinophilic Esophagitis pipeline, and what the future holds for Eosinophilic Esophagitis treatment.